Zynerba Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.8M

285 transactions

Summary

Zynerba Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.4MSales: $186K17 insiders

Date	Insider	Type	Value
2023-10-10	KISNER DANIEL L	D	—
2023-10-10	KISNER DANIEL L	D	—
2023-10-10	KISNER DANIEL L	U	—
2023-10-10	KISNER DANIEL L	U	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	D	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	U	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	A	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	U	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	U	—
2023-10-10	ANIDO ARMANDO(Chairman & Chief Exec. Officer)	U	—
2023-10-10	MOCH KENNETH I	D	—
2023-10-10	MOCH KENNETH I	D	—
2023-10-10	MOCH KENNETH I	U	—
2023-10-10	MOCH KENNETH I	U	—
2023-10-10	Butler John P.	D	—
2023-10-10	Butler John P.	D	—
2023-10-10	Butler John P.	U	—
2023-10-10	Butler John P.	U	—
2023-10-10	Parker Albert P(Chief Legal Officer)	D	—
2023-10-10	Parker Albert P(Chief Legal Officer)	U	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Zynerba Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope